HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexandra Thomas Selected Research

6- N,N- diethyl- beta,gamma- dibromomethylene- D- ATP

1/2022Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexandra Thomas Research Topics

Disease

32Breast Neoplasms (Breast Cancer)
01/2022 - 07/2013
27Neoplasms (Cancer)
01/2022 - 10/2008
6Triple Negative Breast Neoplasms
01/2022 - 02/2015
5Pathologic Complete Response
12/2021 - 07/2013
3Neoplasm Metastasis (Metastasis)
01/2021 - 09/2017
2Heart Failure
02/2021 - 12/2018
2Brain Neoplasms (Brain Tumor)
06/2019 - 01/2018
2Lymphoma (Lymphomas)
12/2018 - 01/2017
1Anemia
11/2021
1Second Primary Neoplasms (Neoplasms, Second)
09/2021
1Cardiotoxicity
09/2021
1COVID-19
01/2021
1Infections
01/2021
1Residual Neoplasm
01/2021
1Neoplasm Micrometastasis
01/2021
1Papillary Thyroid Cancer
12/2020
1follicular Thyroid cancer
12/2020
1Necrosis
08/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2020
1Pneumonia (Pneumonitis)
05/2020
1Peripheral Nervous System Diseases (PNS Diseases)
01/2020
1Colonic Neoplasms (Colon Cancer)
01/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Disease Progression
06/2019
1Leukemia
12/2018
1Sarcoma (Soft Tissue Sarcoma)
12/2018
1Renal Cell Carcinoma (Grawitz Tumor)
12/2018
1Ovarian Neoplasms (Ovarian Cancer)
11/2018
1Vitamin D Deficiency
07/2018
1Noninfiltrating Intraductal Carcinoma (DCIS)
08/2017
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2017

Drug/Important Bio-Agent (IBA)

11Hormones (Hormone)IBA
12/2021 - 04/2014
5Pharmaceutical PreparationsIBA
01/2022 - 01/2017
5human ERBB2 proteinIBA
10/2021 - 07/2013
3Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2017
2Adenosine (Adenocard)FDA LinkGeneric
01/2022 - 01/2021
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2022
2Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2020
2Immune Checkpoint InhibitorsIBA
12/2021 - 01/2019
2Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 01/2014
2Aromatase InhibitorsIBA
10/2021 - 01/2021
2Estrogens (Estrogen)FDA Link
09/2021 - 01/2021
2CytokinesIBA
01/2021 - 01/2020
2Trastuzumab (Herceptin)FDA Link
10/2020 - 01/2020
2taxaneIBA
01/2020 - 12/2016
2Contrast MediaIBA
11/2018 - 09/2018
2Vitamin DFDA LinkGeneric
07/2018 - 01/2018
2Phenobarbital (Luminal)FDA Link
01/2018 - 04/2014
2Estrogen ReceptorsIBA
04/2014 - 07/2013
16- N,N- diethyl- beta,gamma- dibromomethylene- D- ATPIBA
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1EstersIBA
01/2022
1olaparibIBA
12/2021
1durvalumabIBA
12/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2021
1Hemoglobins (Hemoglobin)IBA
11/2021
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
11/2021
1entinostat (MS 275)IBA
10/2021
1exemestane (Aromasin)FDA Link
10/2021
1Histone Deacetylase InhibitorsIBA
10/2021
1Phosphotransferases (Kinase)IBA
05/2021
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2021
1Biological ProductsIBA
01/2021
1COVID-19 VaccinesIBA
01/2021
1Aromatase (CYP19)IBA
01/2021
1VaccinesIBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1RacivirIBA
12/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020
1Anti-Bacterial Agents (Antibiotics)IBA
08/2020
1Syndecan-1 (Syndecan 1)IBA
08/2020
1ChromatinIBA
08/2020
1CaspasesIBA
08/2020
1EchinomycinIBA
08/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1CopperIBA
01/2020
1activin AIBA
01/2020
1AnthracyclinesIBA
01/2020
1CateninsIBA
06/2019
1Calcium Channels (Calcium Channel)IBA
06/2019
1p38 Mitogen-Activated Protein KinasesIBA
06/2019
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
06/2019
1Blocking AntibodiesIBA
01/2019
1LigandsIBA
01/2019
1Silicon Dioxide (Silica)FDA LinkGeneric
11/2018
1AntibodiesIBA
01/2018
1Nucleic Acid ProbesIBA
09/2017

Therapy/Procedure

13Therapeutics
01/2022 - 03/2010
8Neoadjuvant Therapy
01/2022 - 07/2013
8Drug Therapy (Chemotherapy)
02/2021 - 07/2013
5Radiotherapy
01/2020 - 10/2008
3Mastectomy (Mammectomy)
08/2017 - 07/2013
2Adjuvant Chemotherapy
01/2021 - 01/2020
1Immunotherapy
01/2022
1Lasers (Laser)
01/2022
1Traction
01/2020
1Precision Medicine
11/2018
1Breast Implants (Breast Implant)
01/2017